RBC Capital Reiterates Outperform on Johnson & Johnson, Maintains $181 Price Target
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Shagun Singh has reiterated an Outperform rating on Johnson & Johnson (NYSE:JNJ) and maintained a price target of $181.
January 24, 2024 | 4:21 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
RBC Capital analyst reaffirms Outperform rating on JNJ with a $181 price target, indicating a positive outlook on the stock.
The reiteration of an Outperform rating by a major analyst like RBC Capital typically instills confidence in investors and can have a positive impact on the stock price in the short term. The maintained price target of $181 suggests that the analyst sees potential for the stock to rise to that level, which is also a positive signal for the stock.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100